1. Home
  2. HGLB vs ACOG Comparison

HGLB vs ACOG Comparison

Compare HGLB & ACOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Highland Global Allocation Fund

HGLB

Highland Global Allocation Fund

HOLD

Current Price

$6.89

Market Cap

174.3M

Sector

Finance

ML Signal

HOLD

Logo Alpha Cognition Inc.

ACOG

Alpha Cognition Inc.

HOLD

Current Price

$8.36

Market Cap

193.6M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
HGLB
ACOG
Founded
N/A
2000
Country
United States
Canada
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
174.3M
193.6M
IPO Year
2015
2024

Fundamental Metrics

Financial Performance
Metric
HGLB
ACOG
Price
$6.89
$8.36
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
★ $16.00
AVG Volume (30 Days)
65.2K
★ 109.0K
Earning Date
01-01-0001
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 41.58
EPS
★ N/A
N/A
Revenue
N/A
★ $10,220,275.00
Revenue This Year
N/A
$139.22
Revenue Next Year
N/A
$134.48
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.98
$4.50
52 Week High
$10.64
$10.14

Technical Indicators

Market Signals
Indicator
HGLB
ACOG
Relative Strength Index (RSI) 23.45 41.67
Support Level N/A $8.30
Resistance Level $7.67 $9.04
Average True Range (ATR) 0.14 0.53
MACD -0.03 -0.08
Stochastic Oscillator 3.37 12.41

Price Performance

Historical Comparison
HGLB
ACOG

About HGLB Highland Global Allocation Fund

Highland Global Allocation Fund is a diversified, closed-end management investment company. The investment objective of the Fund is to seek long-term growth of capital and future income. The Fund seeks to achieve its investment objectives by investing in a portfolio of U.S. and foreign equity, debt, and money market securities. It may also invest in senior loans to domestic or foreign corporations, partnerships, and other entities that operate in a variety of industries and geographic regions.

About ACOG Alpha Cognition Inc.

Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimers disease, for which there are limited or no treatment options. The Companies current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Companies commercial development program for ZUNVEYL is focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.

Share on Social Networks: